Literature DB >> 3721124

Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease.

R P MacDermott, G S Nash, M J Bertovich, R F Mohrman, I J Kodner, D L Delacroix, J P Vaerman.   

Abstract

Intestinal mononuclear cells (MNC) from patients with inflammatory bowel disease (IBD) demonstrated altered patterns of spontaneous secretion of immunoglobulin A (IgA). Control intestinal MNC had markedly high spontaneous secretion of IgA compared to IBD intestinal MNC. Control intestinal MNC secreted predominantly dimeric IgA (only 31% monomeric IgA), whereas IBD intestinal MNC secreted increased amounts (43%-53%) of monomeric IgA. Control intestinal MNC secreted 61% IgA subclass 1 (IgA1), whereas IBD intestinal MNC secreted 71%-74% IgA1. Intestinal MNC from involved portions of resected specimens secreted more of both monomeric IgA and IgA1 than MNC from uninvolved areas of the same bowel. Therefore, intestinal MNC from involved IBD intestinal specimens secrete less total IgA but high percentages of monomeric IgA and IgA1 compared to control intestinal MNC. This could be caused by increased homing of monomeric IgA- and IgA1-producing cells into involved intestine, or the in situ proliferation of monomeric IgA and IgA1 precursor cells resulting from immunoregulatory alterations. These observations may represent the normal mucosal IgA immune response to infectious agents or inducing factors of either a primary or a secondary nature.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3721124     DOI: 10.1016/0016-5085(86)90572-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

Review 1.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Monomeric IgG2a promotes maturation of bone-marrow macrophages and expression of the mannose receptor.

Authors:  S Schreiber; J S Blum; W F Stenson; R P MacDermott; P D Stahl; S L Teitelbaum; S L Perkins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  Ten-year follow-up study of linear immunoglobulin A dermatosis complicated with ulcerative colitis.

Authors:  Hiroki Sonoyama; Yoshiyuki Mishima; Shunji Ishihara; Naoki Oshima; Ichiro Moriyama; Kousaku Kawashima; Yuko Chinuki; Eishin Morita; Yoshikazu Kinoshita
Journal:  Clin J Gastroenterol       Date:  2019-09-25

4.  Immunoglobulin secretion by isolated intestinal lymphocytes: spontaneous production and T-cell regulation in normal small intestine and in patients with coeliac disease.

Authors:  J E Crabtree; R V Heatley; M L Losowsky
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

5.  Immunoglobulin production by isolated intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  K C Wu; Y R Mahida; J D Priddle; D P Jewell
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

6.  Immunological study of histologically non-involved jejunum during Crohn's disease: evidence for reduced in vivo secretion of secretory IgA.

Authors:  P Marteau; J F Colombel; J Nemeth; J P Vaerman; J C Dive; J C Rambaud
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  Normal human intestinal B lymphocytes. Increased activation compared with peripheral blood.

Authors:  M G Peters; H Secrist; K R Anders; G S Nash; S R Rich; R P MacDermott
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

Review 8.  Etiopathogenesis of inflammatory bowel diseases.

Authors:  Silvio Danese; Claudio Fiocchi
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

9.  Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease.

Authors:  B R Yacyshyn; L M Pilarski
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

10.  Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.

Authors:  R P MacDermott; S Schreiber; G S Nash; W J Koopman
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.